MC
CVS icon

Maverick Capital’s CVS Health CVS Stock Holding History

Maverick Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,472
Closed -$680K – 211
2026
Q1 		$680K Buy
+9,472
New +$730K 0.01% 193
2023
Q4 		– Sell
-22,676
Closed -$1.58M – 380
2023
Q3 		$1.58M Buy
22,676
+6,916
+44% +$490K 0.04% 90
2023
Q2 		$1.09M Buy
15,760
+8,842
+128% +$629K 0.02% 156
2023
Q1 		$514K Buy
6,918
+4,345
+169% +$364K 0.01% 251
2022
Q4 		$240K Buy
+2,573
New +$248K 0.01% 346
2021
Q2 		– Sell
-11,556
Closed -$869K – 708
2021
Q1 		$869K Buy
+11,556
New +$842K 0.01% 286
2020
Q4 		– Sell
-13,166
Closed -$769K – 699
2020
Q3 		$769K Buy
13,166
+12,902
+4,887% +$803K 0.01% 342
2020
Q2 		$17K Buy
+264
New +$16.6K ﹤0.01% 554

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Maverick Capital's CVS Position: Q2 2026 in Review

Maverick Capital sold out of CVS Health (CVS) in Q2 2026, closing a stake of 9,472 shares — an estimated $680K sold.

Maverick Capital first reported a position in CVS in Q2 2020 and held it in 8 quarters. The position peaked at $1.58M in Q3 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Maverick Capital reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Maverick Capital sold 9,472 CVS Health shares in Q2 2026, an estimated $680K.
  • Maverick Capital first reported a position in CVS Health in Q2 2020 and held it in 8 quarters.
  • Maverick Capital's CVS Health position peaked at $1.58M in Q3 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.